Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Procept BioRobotics Corp (NASDAQ: PRCT) closed at $97.40 in the last session, down -1.69% from day before closing price of $99.07. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 1.06 million shares were traded. PRCT stock price reached its highest trading level at $103.8099 during the session, while it also had its lowest trading level at $95.545.
Ratios:
We take a closer look at PRCT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.07 and its Current Ratio is at 6.02. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 11, 2023, initiated with a Overweight rating and assigned the stock a target price of $42.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 07 ’24 when Desai Antal Rohit sold 34,000 shares for $95.39 per share. The transaction valued at 3,243,158 led to the insider holds 164,363 shares of the business.
Desai Antal Rohit sold 33,000 shares of PRCT for $3,202,444 on Nov 06 ’24. The Director now owns 198,363 shares after completing the transaction at $97.04 per share. On Nov 05 ’24, another insider, Desai Antal Rohit, who serves as the Director of the company, sold 33,000 shares for $96.60 each. As a result, the insider received 3,187,835 and left with 231,363 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 5269953536 and an Enterprise Value of 4968518144. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.29 while its Price-to-Book (P/B) ratio in mrq is 21.06. Its current Enterprise Value per Revenue stands at 24.862 whereas that against EBITDA is -49.018.
Stock Price History:
Over the past 52 weeks, PRCT has reached a high of $99.35, while it has fallen to a 52-week low of $29.71. The 50-Day Moving Average of the stock is 22.06%, while the 200-Day Moving Average is calculated to be 52.32%.
Shares Statistics:
According to the various share statistics, PRCT traded on average about 864.15K shares per day over the past 3-months and 1672090 shares per day over the past 10 days. A total of 50.77M shares are outstanding, with a floating share count of 48.98M. Insiders hold about 5.74% of the company’s shares, while institutions hold 85.86% stake in the company. Shares short for PRCT as of 1728950400 were 6706552 with a Short Ratio of 7.76, compared to 1726185600 on 5695289. Therefore, it implies a Short% of Shares Outstanding of 6706552 and a Short% of Float of 17.629998999999998.
